
Tesamorelin,Ipa,CJC1295 6/3/3(Blend)

Tesamorelin,Ipa,CJC1295 6/3/3(Blend)
This triple combination is used to study the multi-level synergistic regulatory mechanisms of the growth hormone axis. Tesamoreli primarily acts on upstream regulatory signals, Ipa stimulates growth hormone release through selective pathways, while CJC-1295 prolongs the duration of endogenous signaling. By covering distinct regulatory nodes, this triad enables systematic investigation of GH secretion rhythms, feedback control, and endocrine system synergism. This combination holds significant model research value for studies on the growth axis, circadian rhythms, and metabolism.
The peptide will be provided as lyophilized powder to ensure maximum stability.
$200
RUO — For research use only. Not for use in humans or animals.
Technical Information
Downloads & Documents
Review available batch-specific testing documentation for Tesamorelin,Ipa,CJC1295 6/3/3(Blend), or contact us to request the certificate supplied with your batch.
Handling & Research Notice
- Reconstitute under sterile conditions and use aseptic technique.
- Store reconstituted material at 2-8°C and use within research protocol limits.
- Avoid repeated freeze-thaw cycles to preserve peptide integrity.
- For laboratory research use only — not for human or veterinary use, and not for diagnostic or therapeutic purposes.
Contact Us Now for A Quote
Wholesale pricing, batch COA documents and direct product support.



